Novonesis (NZM2) Stock Forecast & Price Target

6 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NZM2 Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Novonesis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NZM2 Stock 12 Month Forecast

Average Price Target

€65.74

▲(17.56% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Novonesis in the last 3 months. The average price target is €65.74 with a high forecast of €71.57 and a low forecast of €55.51. The average price target represents a 17.56% change from the last price of €55.92.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"48":"€48","54":"€54","60":"€60","66":"€66","72":"€72"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":71.56695,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€71.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65.7384,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€65.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55.51455,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€55.51</span>\n  </div></div>","useHTML":true}}],"tickPositions":[48,54,60,66,72],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.047,57.240842307692304,58.43468461538461,59.62852692307692,60.82236923076923,62.01621153846154,63.21005384615385,64.40389615384615,65.59773846153847,66.79158076923078,67.98542307692308,69.17926538461539,70.3731076923077,{"y":71.56695,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.047,56.79249230769231,57.537984615384616,58.28347692307692,59.02896923076923,59.77446153846154,60.51995384615385,61.26544615384615,62.01093846153846,62.75643076923077,63.50192307692308,64.24741538461538,64.9929076923077,{"y":65.7384,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.047,56.006042307692304,55.96508461538461,55.92412692307692,55.88316923076923,55.842211538461534,55.80125384615384,55.760296153846156,55.71933846153846,55.67838076923077,55.63742307692308,55.596465384615385,55.55550769230769,{"y":55.51455,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":54.704,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.224,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.612,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.023,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.696,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.433,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.106,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.61,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.928,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.078,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.37,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.047,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€71.57

Average Price Target€65.74

Lowest Price Target€55.51

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sebastian Bray

Berenberg Bank

€56.45→€66.89

Buy

19.61%

Upside

Reiterated

08/24/26

Novonesis price target raised to DKK 500 from DKK 422 at BerenbergNovonesis price target raised to DKK 500 from DKK 422 at Berenberg

Lisa De Neve

Morgan Stanley

€69.56→€71.57

Buy

27.98%

Upside

Reiterated

08/21/26

Morgan Stanley Sticks to Its Buy Rating for Novonesis (0Q4U)

Alex Sloane

Barclays

€66.89

Buy

19.61%

Upside

Reiterated

08/20/26

Novonesis (0Q4U) Gets a Buy from Barclays

Chetan Udeshi

J.P. Morgan

€66.89→€69.56

Buy

24.39%

Upside

Reiterated

07/08/26

Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan

Nicola Tang

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€48.42→€55.51

Hold

-0.73%

Downside

Upgraded

07/03/26

Novonesis upgraded to Neutral from Underperform at BNP ParibasNovonesis upgraded to Neutral from Underperform at BNP Paribas

Marcus Dunford-Castro

Jefferies

€60.2→€64.21

Buy

14.82%

Upside

Reiterated

07/02/26

Jefferies Sticks to Its Buy Rating for Novonesis (0Q4U)

Virginie Boucher-Ferte

Deutsche Bank

€64.21→€65.55

Buy

17.22%

Upside

Reiterated

06/30/26

Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank

Philip Ngotho

Kepler Capital

€61.53

Buy

10.04%

Upside

Reiterated

05/18/26

Novonesis (0Q4U) Gets a Buy from Kepler Capital

Ranulf Orr

Citi

€55.51→€58.86

Buy

5.26%

Upside

Reiterated

05/08/26

Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi

Artem Chubarov

Rothschild & Co Redburn

€59.53

Buy

6.45%

Upside

Upgraded

03/27/26

Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn

Georgina Fraser CFA

Goldman Sachs

€73.57

Buy

31.57%

Upside

Reiterated

11/11/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Eden

UBS

€62.87→€59.53

Buy

6.45%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sebastian Bray

Berenberg Bank

€56.45→€66.89

Buy

19.61%

Upside

Reiterated

08/24/26

Novonesis price target raised to DKK 500 from DKK 422 at BerenbergNovonesis price target raised to DKK 500 from DKK 422 at Berenberg

Lisa De Neve

Morgan Stanley

€69.56→€71.57

Buy

27.98%

Upside

Reiterated

08/21/26

Morgan Stanley Sticks to Its Buy Rating for Novonesis (0Q4U)

Alex Sloane

Barclays

€66.89

Buy

19.61%

Upside

Reiterated

08/20/26

Novonesis (0Q4U) Gets a Buy from Barclays

Chetan Udeshi

J.P. Morgan

€66.89→€69.56

Buy

24.39%

Upside

Reiterated

07/08/26

Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan

Nicola Tang

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€48.42→€55.51

Hold

-0.73%

Downside

Upgraded

07/03/26

Novonesis upgraded to Neutral from Underperform at BNP ParibasNovonesis upgraded to Neutral from Underperform at BNP Paribas

Marcus Dunford-Castro

Jefferies

€60.2→€64.21

Buy

14.82%

Upside

Reiterated

07/02/26

Jefferies Sticks to Its Buy Rating for Novonesis (0Q4U)

Virginie Boucher-Ferte

Deutsche Bank

€64.21→€65.55

Buy

17.22%

Upside

Reiterated

06/30/26

Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank

Philip Ngotho

Kepler Capital

€61.53

Buy

10.04%

Upside

Reiterated

05/18/26

Novonesis (0Q4U) Gets a Buy from Kepler Capital

Ranulf Orr

Citi

€55.51→€58.86

Buy

5.26%

Upside

Reiterated

05/08/26

Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi

Artem Chubarov

Rothschild & Co Redburn

€59.53

Buy

6.45%

Upside

Upgraded

03/27/26

Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn

Georgina Fraser CFA

Goldman Sachs

€73.57

Buy

31.57%

Upside

Reiterated

11/11/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Eden

UBS

€62.87→€59.53

Buy

6.45%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novonesis

3 Months

Charles EdenUBS

Success Rate

11/17 ratings generated profit

Average Return

+0.34%

Copying Charles Eden's trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +0.34% per trade.

1 Year

Chetan UdeshiJ.P. Morgan

Success Rate

9/12 ratings generated profit

Average Return

+7.78%

Copying Chetan Udeshi's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +7.78% per trade.

2 Years

Chetan UdeshiJ.P. Morgan

Success Rate

11/12 ratings generated profit

Average Return

+12.07%

Copying Chetan Udeshi's trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +12.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NZM2 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NZM2 has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NZM2 average Analyst price target in the past 3 months is 65.74.

Each month's total comprises the sum of three months' worth of ratings.

NZM2 Financial Forecast

NZM2 Earnings Forecast

Next quarter’s earnings estimate for NZM2 is €0.79 with a range of €0.56 to €1.01. The previous quarter’s EPS was €0.38. NZM2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year NZM2 has Performed in-line its overall industry.

NZM2 Sales Forecast

Next quarter’s sales forecast for NZM2 is €1.15B with a range of €1.14B to €1.17B. The previous quarter’s sales results were €1.12B. NZM2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year NZM2 has Performed in-line its overall industry.

NZM2 Stock Forecast FAQ

What is DE:NZM2’s average 12-month price target, according to analysts?

Based on analyst ratings, Novonesis’s 12-month average price target is 65.74.

What is DE:NZM2’s upside potential, based on the analysts’ average price target?

Novonesis has 17.56% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Novonesis a Buy, Sell or Hold?

Novonesis has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Novonesis’s share price target?

The average share price target for Novonesis is 65.74. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €71.57 ,and the lowest forecast is €55.51. The average share price target represents 17.56% Increase from the current price of €55.92.

What do analysts say about Novonesis?

Novonesis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Novonesis?

To buy shares of DE:NZM2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Novonesis (NZM2) Stock Forecast & Price Target

NZM2 Analyst Ratings

NZM2 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Novonesis

NZM2 Analyst Recommendation Trends

NZM2 Financial Forecast

NZM2 Earnings Forecast

NZM2 Sales Forecast

NZM2 Stock Forecast FAQ

Detailed List of Analyst Forecasts